最新消息

MALAYSIA: MDA Regulatory Updates - Publication of Third Edition Guidance on Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application – April/May 2026

MALAYSIA: MDA Regulatory Updates - Publication of Third Edition Guidance on Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application – April/May 2026

  • 2026-05-27 09:53:25

The Medical Device Authority (MDA) has published the latest edition of Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application, MDA/GD/0043, which outlines the eligibility of personnel authorized to apply for the exemptions, specifies the procedures for notification, applicant responsibilities, and use of unregistered medical devices. The document is intended to facilitate timely access to medical devices for specific needs in healthcare settings.

了解更多
Philippines: Effectivity of the Implementing Guidelines for the Post-Marketing Alert System (PMAS) Requirements, Annex 5 of the ASEAN Medical Device Directive (AMDD) – April/May 2026

Philippines: Effectivity of the Implementing Guidelines for the Post-Marketing Alert System (PMAS) Requirements, Annex 5 of the ASEAN Medical Device Directive (AMDD) – April/May 2026

  • 2026-05-27 01:54:19

Effective May 6, 2026, Administrative Order No. 2025-0030 establishes a mandatory Post-Marketing Alert System (PMAS) for medical devices in the Philippines, aligning national policy with the ASEAN Medical Device Directive. The order requires manufacturers, traders, and distributors to maintain strict traceability records, report adverse events within 48 hours to 30 days, and implement Field Safety Corrective Actions to mitigate risks. A one-year transition period for industry compliance has officially commenced.

了解更多
MALAYSIA: Joint Announcement for Full Implementation of Medical Devic Regulatory Reliance Programmed Between MDA (Malaysia) and Thai FDA (Thailand) – April/May 2026

MALAYSIA: Joint Announcement for Full Implementation of Medical Devic Regulatory Reliance Programmed Between MDA (Malaysia) and Thai FDA (Thailand) – April/May 2026

  • 2026-05-22 06:47:10

The Medical Device Authority (MDA) of Malaysia and the Thailand Food and Drug Administration (Thai FDA) have officially announced the successful completion of a three-month pilot phase, which took place from 1 February 2026 to 30 April 2026. Following this pilot phase, the full implementation of the MDA–Thai FDA Medical Device Regulatory Reliance Programme will now apply to the registration of Class B, Class C, and Class D medical devices.

了解更多
QT Activity: Webinar Recap | EU MDR 2026 Update: Practical Insights on Transition, Documentation & Compliance Strategy – April/May 2026

QT Activity: Webinar Recap | EU MDR 2026 Update: Practical Insights on Transition, Documentation & Compliance Strategy – April/May 2026

  • 2026-05-22 02:22:56

As EU MDR expectations continue to intensify in 2026, manufacturers are facing greater scrutiny across technical documentation, clinical evidence, and lifecycle compliance. Qualtech's webinar recap highlights practical insights on MDR transition planning, Annex XVI obligations, notified body expectations, and key compliance priorities shaping EU market access strategies.

了解更多
Malaysia: MDA Regulatory Updates – Publication of Second Edition Guidance on Definition of Medical Device – March/April 2026

Malaysia: MDA Regulatory Updates – Publication of Second Edition Guidance on Definition of Medical Device – March/April 2026

  • 2026-04-28 08:33:22

The Medical Device Authority (MDA) has published the latest edition of the guidance document Definition of Medical Device which provides additional clarification on the definition and regulatory interpretation of medical devices, including accessories, components, and spare parts. The document is intended to assist industry stakeholders in the proper identification of device classifications and ensuring compliance with the Medical Device Act 2012 (Act 737).

了解更多
Malaysia: MDA Regulatory Updates – Publication of First Edition Application for Confirmation Status of Obsolete and Discontinued Medical Device – March/April 2026

Malaysia: MDA Regulatory Updates – Publication of First Edition Application for Confirmation Status of Obsolete and Discontinued Medical Device – March/April 2026

  • 2026-04-28 08:14:56

The Medical Device Authority (MDA) has published the new guidance document, Application for Confirmation Status of Obsolete and Discontinued Medical Device (MDA/GD/0071). This publication was to assist establishments and healthcare professionals in understanding the applicable regulatory framework and in implementing appropriate control measures for obsolete and discontinued medical devices.

了解更多
Japan: FAQs and Key Points on SaMD – March/April 2026

Japan: FAQs and Key Points on SaMD – March/April 2026

  • 2026-04-28 01:22:14

In alignment with the latest regulatory guidance on SaMD and cybersecurity for network-connected devices, the framework for managing ancillary network infrastructure (such as VPN gateways) has been refined. This includes an extensive definition of responsible matrices, lifecycle security maintenance, and the implementation of proactive security controls to mitigate cyber risks.

了解更多
SINGAPORE: HSA responds to consultation on proposed AI-SaMD licensing and registration exemption for selected public healthcare entities – February/March 2026

SINGAPORE: HSA responds to consultation on proposed AI-SaMD licensing and registration exemption for selected public healthcare entities – February/March 2026

  • 2026-04-02 01:20:01

Health Sciences Authority (HSA) has responded to feedback from its public consultation on a proposed regulatory sandbox that exempts selected low‑risk artificial intelligence software as a medical device (AI‑SaMD) from manufacturer licensing and product registration requirements under controlled conditions. The sandbox aims to balance regulatory oversight and innovation by allowing public healthcare institutions to develop and deploy AI tools for non‑critical medical conditions while collecting real‑world insights to inform future regulatory frameworks.

了解更多
Qualech Webinar: From Paperwork to Practice – Mastering EU MDR Technical Documentation – April 2026

Qualech Webinar: From Paperwork to Practice – Mastering EU MDR Technical Documentation – April 2026

  • 2026-04-01 07:49:34

Qualtech invites you to a free webinar on April 17, 2026, on mastering Technical Documentation under the EU Medical Device Regulation (MDR). Regulatory expert Dr. Arkan Zwick will share practical guidance on MDR documentation, Annex XVI requirements, legacy device transitions, and working with notified bodies. The session provides valuable insights for all medical device manufacturers currently active in, or planning to enter, the European market.

了解更多
MALAYSIA: MDA Regulatory Updates – Requirement of Labelling Guidance Document & HSA Verification Approvals – February/March 2026

MALAYSIA: MDA Regulatory Updates – Requirement of Labelling Guidance Document & HSA Verification Approvals – February/March 2026

  • 2026-04-01 07:01:44

The Medical Device Authority (MDA), Malaysia, announces two key updates for medical device registration. The latest labelling guidance introduces e-labelling requirements, while conformity assessments conducted by Singapore's Health Sciences Authority (HSA) are now recognized through a verification-based process. These updates aim to streamline registration and ensure compliance for medical devices in Malaysia.

了解更多